FFCP PHASE2:Hg19::chr6:27782876..27782889,+
From FANTOM5_SSTAR
Jump to: navigation, search
| Short description: | p2@HIST1H2BM |
|---|---|
| Species: | Human (Homo sapiens) |
| DPI dataset: | Robust |
| TSS-like-by-RIKEN-classifier(Yes/No): | Yes |
| DHS support(Yes/No): | Yes |
| Description: | CAGE_peak_2_at_HIST1H2BM_5end |
| Coexpression cluster: | C62_Burkitt_tonsil_CD19_submaxillary_spleen_salivary_lymph |
| Association with transcript: | 54bp_to_BC066244, BC067485, BC067486, BC067487, BC067488, BC067489_5end |
| EntrezGene: | HIST1H2BM |
| HGNC: | 4750 |
| UniProt: | Q99879 |
| Genome view: | ZENBU |
View on UCSC genome browser
Mouse over to see Genome browser image, Click image to go to Genome browser
CAGE Expression
| Sample | p2@HIST1H2BM |
|---|
0
25
50
75
100
125
150
175
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
| Ontology term | p-value | n |
|---|---|---|
| hematologic cancer | 3.58e-13 | 51 |
| immune system cancer | 3.58e-13 | 51 |
| lymphoma | 7.52e-11 | 10 |
| leukemia | 3.84e-08 | 39 |
Showing 1 to 4 of 4 entries
